Epigenetics

Ask a question about this product »

Summary

This report analyzes the Global market for Epigenetics in US$ Million by the following Application Areas: Drug Discovery, Diagnostics, and Others. Annual forecasts are provided for the period 2006 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Contents

• I.Introduction, Methodology & Product Definitions
• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• II. Executive Summary
• 1.Industry Overview
  • Epigenetics: An Introduction
  • Cancer: The Key Focus Area for Epigenetics
  • Histone Changes as Biomarkers: An Emerging Field
  • Future of Epigenetics
• 2.Global Market Overview
  • Scope of Epigenetics
  • Oncology
  • Psychiatry
  • Outlook of Epigenetic Treatments
  • Current and Future Analysis
  • Market Segmentation
  • Therapeutics
  • Diagnostics
  • Research Tools
  • Epigenetics Stretching to Hesc Research
  • Epigenetics: Transforming from Special Niche to Widespread Collection of Tools
  • Pros and Cons of First Generation Epigenetics Drugs
  • Advances in Epigenetics Technologies, Therapeutics and Diagnostics
  • Outlook for Product Positioning and Innovation
  • Epigenetic Community Initiatives
  • Patent Law in Japan
• 3.Competition
  • Epigenomics Pioneers The Epigenetics Diagnostics
  • Merck Leads Hdac Inhibitors Market
  • Huge Potential for Novel Therapies
  • Combination Therapy
  • Novel Technologies
• 4.Product Overview
  • Epigenetics - Definition
  • Categories of Signals in Epigenetics
  • Introduction
  • Etymology and Meaning
  • Epigenetics - Molecular Base
  • Mechanisms
  • Chromatin Remodeling and DNA Methylation
  • Rna Transcripts and Programmed Proteins
  • Prions
  • Structural Inheritance Systems
  • Functions and Outcomes
  • Development
  • Medicine
  • Evolution
  • Epigenetics in Microorganisms
• 5.Product Launches
  • Epigentek Group Launches New Measures for DNA Methylation Shifts
  • Qiagen Introduces Epitect® Hrm™ Pcr Kit
  • Enzo Biochem Rolls out Wide-Ranging Epigenetics Tools
  • Applied Biosystems Unveils Novel Small Rna Expression Analysis Solution
  • Sigma-Aldrich Launches Imprint™ Methylated DNA Quantification Kit
  • Sigma-Aldrich Unveils Chip Kit for Epigenetic Research
  • Pyrosequencing Introduces New Pyromark™ Q24
  • Qiagen Expands Epitect Portfolio
  • Applied Biosystems Introduces New Solid™ 3 System
• 6.Recent Industry Activity
  • Merck Merges with Schering-Plough
  • Celldex Therapeutics Acquires Curagen
  • Nccn Upgrades Vidaza to Category 1
  • Prognosdx Health Obtains Ucla Epigenetics Technology Rights
  • Progen Posts Positive Results from Preclinical Epigenetics Product
  • Pharmacyclics Announces Positive Scientific Results from Pci-24781 Clinical Trial Targeting Hdac
  • Cellcentric Signs Agreement with Takeda
  • Orion Genomics and Novartis Ink Multi-Year Collaboration and License Agreement
  • Supergen Collaborates with Glaxosmithkline
  • Qiagen to Acquire Sabiosciences
  • Qiagen Takes over Dxs
  • Cellcentric Expands Number of Researchers
  • Roche Nimblegen Enters into Collaboration with Sigma-Aldrich
  • Quest Diagnostics Gains Biomarker License from Epigenomics
  • Babraham Institute Launches New Epigenomics Sequencing Facility
  • Active Motif Enters into Licensing Agreement with City of Hope
  • Nih to Grant US$62 Million for Epigenetic Research
  • Rush University Medical Center Obtains US$5.5 Million Grant from Nih
  • Celgene Takes over Pharmion
  • Eisai Takes over Mgi Pharma
  • Affymetrix Acquires Panomics
  • Qiagen Takes over Biotage's Biosystems
  • Millipore Corporation and Agilent Technologies Collaborate
  • Invitrogen Signs License Agreement with Genisphere
  • Invitrogen and Imbcom Proprietary Ink Licensing Agreement
  • Oncomethylome Sciences and Qiagen Sign Licensing Agreement
  • Pharmacyclics Characterizes Highly Selective Hdac Inhibitor
  • Celgene's Vidaza Gains Approval for Mds and Aml in Europe
  • Medistem Enters into Epigenetics Collaboration
  • Orion Geomics Obtains License for Igf2 Gene from Johns Hopkins
  • Progen Pharmaceuticals Acquires Cellgate
  • Bioserve Purchases Genomics Collaborative
  • Sigma-Aldrich and Epigentek Signs Licensing Agreement
  • Constellation Pharmaceuticals and Biotrove Enter into R&d Collaboration
• 7.Recent Research Findings
  • Salk Institute Researchers Present Full Epigenome Map
  • Baylor College of Medicine Recognizes Epigenetic Affects on Obesity
  • Prenatal Starvation Could Cause Epigenetic Modifications
  • John Hopkins Scientists Reveal Epigenetic Modifications Take Place over Lifetime
  • Advances in Epigentic Regulation Focuses on Breast Cancer
• 8.Focus on Select Players
  • Celgene Corporation (US)
  • Cellcentric Ltd. (UK)
  • Epigenomics Ag (Germany)
  • Epigentek Group, Inc. (US)
  • Genpathway, Inc. (US)
  • Merck & Co., Inc. (US)
  • Mgi Pharma, Inc. (US)
  • Millipore Corporation (US)
  • Oncomethylome Sciences S.A (Belgium)
  • Orion Genomics (US)
• 9.Global Market Perspective
  • Table 1: World Recent past, Current & Future Analysis for Epigenetics by Application Area - Drug Discovery, Diagnostics and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (Includes Corresponding Graph/Chart)
  • Table 2: World 10-Year Perspective for Epigenetics by Application Area - Percentage Breakdown of Dollar Sales for Drug Discovery, Diagnostics, and Others Markets for Years 2006, 2009, & 2015 (Includes Corresponding Graph/Chart)
  • III. Competitive Landscape
  • Total Companies Profiled: 39 (Including Divisions/Subsidiaries - 42)
  • Region/Countryplayers
  • The United States
  • Canada
  • Japan
  • Europe
  • Germany
  • The United Kingdom
  • Rest of Europe
  • Asia-Pacific (Excluding Japan)

Related products